Chien-liang Lin

This early-stage trial is testing a new drug, LH-001, in 56 healthy adults aged 18 to 60. The goal is to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and measure drug levels …